Caverzasio et al., Endocrinology 2007
:
In conclusion, Wnt3a activates ERK and p38 in mesenchymal C3H10T1/2 cells by a low-density lipoprotein-receptor related protein-5/6 independent mechanism
Bikkavilli et al., J Cell Sci 2008
:
Chemical inhibitors of JNK ( SP600125 ), but not p38 ( SB203580 ), block WNT3a activation of JNK, whereas both the inhibitors attenuate the WNT3a-beta-catenin pathway